Benefits and Risks of Pharmacotherapy for Dysthymia: A Systematic Appraisal of the Evidence

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.1, 2003-01, pp. : 55-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits and Risks of Pharmacotherapy for Narcolepsy

By Mitler M.M. Hayduk R.

Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. : 791-809

Adis International

Access to resources Recommend Favorite

Off-Label Trazodone Prescription: Evidence, Benefits and Risks

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3343-3351

Bentham Science Publishers

Access to resources Recommend Favorite

Risks and Benefits of Preoperative High Dose Methylprednisolone in Surgical Patients: A Systematic Review

By Sauerland S.

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 449-461

Adis International

Access to resources Recommend Favorite

More evidence is needed to confirm the benefits and risks of many botanicals in dermatology

Drugs & Therapy Perspectives, Vol. 27, Iss. 7, 2011-07 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Benefits and Risks of Antipsychotic Polypharmacy: An Evidence-Based Review of the Literature

By Tranulis Constantin

Drug Safety, Vol. 31, Iss. 1, 2008-01 ,pp. : 7-20

Adis International

Access to resources Recommend Favorite